Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Zhi‐Yi Lv"'
Autor:
Yu‐Min Zhong, Ji Chen, Jie Jiang, Wen‐Bin Zhou, Ling‐Ling Gao, Shui‐Lian Zhang, Wen‐Qing Yan, Yu Chen, Dong‐Kun Zhang, Dan‐Xia Lu, Zhi‐Yi Lv, Zhi Xie, Ying Huang, Wei‐Bang Guo, Bin‐Chao Wang, Jin‐Ji Yang, Xue‐Ning Yang, Yi‐Long Wu, Xu‐Chao Zhang
Publikováno v:
Clinical & Translational Immunology, Vol 13, Iss 6, Pp n/a-n/a (2024)
Abstract Objectives Primary pulmonary lymphoepithelioma‐like carcinoma (PLELC) is a subtype of lung carcinoma associated with the Epstein–Barr virus (EBV). The clinical predictive biomarkers of immune checkpoint blockade (ICB) in PLELC require fu
Externí odkaz:
https://doaj.org/article/f6dc1728bee64dd9a6c7fb2fe41988fd
Autor:
Jia-Tao Zhang, Juan Zhang, Song-Rong Wang, Li-Xu Yan, Jing Qin, Kai Yin, Xiang-Peng Chu, Meng-Min Wang, Hui-Zhao Hong, Zhi-Yi Lv, Song Dong, Ben-Yuan Jiang, Xu-Chao Zhang, Xiang Liu, Qing Zhou, Yi-Long Wu, Wen-Zhao Zhong
Publikováno v:
iScience, Vol 26, Iss 10, Pp 107699- (2023)
Summary: Pulmonary nodules with part-solid imaging features manifest during the progression from preinvasive to invasive lung adenocarcinoma. To define the spatial composition and evolutionary trajectories of early-stage lung adenocarcinoma, we combi
Externí odkaz:
https://doaj.org/article/006216a480c04cc78f0d4e6d7c0343c7
Autor:
Lin‐Lin Li, De‐Xiang Zhou, Ming Lu, Dong Zhou, Xiao‐Feng Lin, Yu Chen, Kai Yin, Hui‐Bo Feng, Wei‐Bang Guo, Zhi Xie, Wen‐Qing Yan, Zhi‐Yi Lv, Dan‐Xia Lu, Shui‐Lian Zhang, Xu‐Chao Zhang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 13, Pp 1948-1960 (2022)
Abstract Background Brain metastases (BM) are common in lung cancer. However, data on the status of immune biomarkers in BM lesions remain limited. Methods We retrospectively analyzed PD‐L1 expression and infiltration levels of CD3+, CD4+, CD8+ T c
Externí odkaz:
https://doaj.org/article/96a76278b7814aa6900611b9fcddc7b7
Autor:
Yu-Qing Chen, Ling-Ling Gao, Ling-Cong Kong, Xu-Hui Guan, Huan Yang, Yu-Fa Li, Zhi-Yi Lv, Xu-Chao Zhang, Hui-Ying Liang, Hua-Jun Chen, Yi-Long Wu, Jie Huang, Jin-Ji Yang
Publikováno v:
Cancer Treatment and Research Communications, Vol 35, Iss , Pp 100684- (2023)
Introduction: Recently, several clinical trials of immunotherapy for extensive-stage small-cell lung cancer (ES-SCLC) have shown limited benefits because of unselected patients. Thus, we aimed to explore whether YES-associated protein 1 (YAP-1) and P
Externí odkaz:
https://doaj.org/article/34561e2ac920400c816763499ae46027
Autor:
Hui‐Bo Feng, Yu Chen, Zhi Xie, Jie Jiang, Yu‐Min Zhong, Wei‐Bang Guo, Wen‐Qing Yan, Zhi‐Yi Lv, Dan‐Xia Lu, Hong‐Ling Liang, Fang‐Ping Xu, Jin‐Ji Yang, Xue‐Ning Yang, Qing Zhou, Dong‐Kun Zhang, Zhou Zhang, Shao‐Kun Chuai, Heng‐Hui Zhang, Yi‐Long Wu, Xu‐Chao Zhang
Publikováno v:
Thoracic Cancer, Vol 12, Iss 19, Pp 2564-2573 (2021)
Abstract Background Src homology region 2 domain‐containing phosphatase 2 (SHP2) is a novel target for Kirsten rat sarcoma oncogene (KRAS) mutant cancer. We retrospectively studied the significance of SHP2 in KRAS mutant non‐small cell lung cance
Externí odkaz:
https://doaj.org/article/be1a8728781c4fc394d58581ae7ef6be
Autor:
Yu-Min Zhong, Kai Yin, Yu Chen, Zhi Xie, Zhi-Yi Lv, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Bin-Chao Wang, Wen-Zhao Zhong, Ling-Ling Gao, Wen-Bin Zhou, Ji Chen, Hai-Yan Tu, Ri-Qiang Liao, Dong-Kun Zhang, Shui-Lian Zhang, Dan-Xia Lu, Hong-Bo Zheng, Heng-Hui Zhang, Yi-Long Wu, Xu-Chao Zhang
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Primary pulmonary lymphoepithelioma-like carcinoma (PLELC) is an Epstein–Barr virus (EBV)-related, rare subtype of non-small-cell lung cancer (NSCLC). Immune checkpoint inhibitors (ICI) show durable responses in advanced NSCLC. However, their effec
Externí odkaz:
https://doaj.org/article/3962ac96e92147ac8deafa74f0ed1910
Autor:
Kai Yin, Hui‐Bo Feng, Lin‐Lin Li, Yu Chen, Zhi Xie, Zhi‐Yi Lv, Wei‐Bang Guo, Dan‐Xia Lu, Xue‐Ning Yang, Wen‐Qing Yan, Yi‐Long Wu, Xu‐Chao Zhang
Publikováno v:
Thoracic Cancer, Vol 11, Iss 2, Pp 346-352 (2020)
Abstract Background Primary pulmonary lymphoepithelioma‐like carcinoma (PLELC) is a rare and unique subtype of lung cancer. However, the prevalence of driver alterations, such as epidermal growth factor receptor (EGFR) mutations and anaplastic lymp
Externí odkaz:
https://doaj.org/article/e4e7cbc8ccd4460783c53bd2c8389899
Autor:
Yu-Qing Chen, BD, Yu-Fa Li, MD, Chan-Yuan Zhang, MD, Shi-Ling Zhang, BD, Zhi-Yi Lv, PhD, Song Dong, PhD, Hua-Jun Chen, PhD, Xu-Chao Zhang, PhD, Yi-Long Wu, MD, Jin-Ji Yang, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 12, Pp 100258- (2021)
Introduction: Pulmonary atypical carcinoid (PAC) is a rare subtype of pulmonary neuroendocrine neoplasm. Although EML4-ALK fusion has been detected in PAC, EGFR mutations have not been reported before. Methods: We performed hematoxylin and eosin stai
Externí odkaz:
https://doaj.org/article/feed2174255e4297a73cd4246748ccd1
Autor:
Lin‐Lin Li, De‐Xiang Zhou, Ming Lu, Dong Zhou, Xiao‐Feng Lin, Yu Chen, Kai Yin, Hui‐Bo Feng, Wei‐Bang Guo, Zhi Xie, Wen‐Qing Yan, Zhi‐Yi Lv, Dan‐Xia Lu, Shui‐Lian Zhang, Xu‐Chao Zhang
Publikováno v:
Thoracic Cancer. 13:1948-1960
Autor:
Zhou Zhang, Hong-Ling Liang, Xu-Chao Zhang, Hui-Bo Feng, Heng-Hui Zhang, Dong-Kun Zhang, Jie Jiang, Yu-Min Zhong, Yu Chen, Yi-Long Wu, Wen-Qing Yan, Shao-Kun Chuai, Qing Zhou, Xue-Ning Yang, Zhi-Yi Lv, F. Xu, Jin-Ji Yang, Wei-Bang Guo, Dan-Xia Lu, Zhi Xie
Publikováno v:
Thoracic Cancer, Vol 12, Iss 19, Pp 2564-2573 (2021)
Background Src homology region 2 domain‐containing phosphatase 2 (SHP2) is a novel target for Kirsten rat sarcoma oncogene (KRAS) mutant cancer. We retrospectively studied the significance of SHP2 in KRAS mutant non‐small cell lung cancer (NSCLC)